Fonte: British journal of haematology. Unidade: FM
Assuntos: LINFOMA, TRANSPLANTE HOMÓLOGO, CÉLULAS-TRONCO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRIERLEY, Charlotte K et al. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, v. 184, n. 4, p. 547-557, 2019Tradução . . Disponível em: https://doi.org/10.1111/bjh.15685. Acesso em: 15 nov. 2024.APA
Brierley, C. K., Jones, F. M., Hanlon, K., Peniket, A. J., Hatton, C., Collins, G. P., et al. (2019). Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies. British journal of haematology, 184( 4), 547-557. doi:10.1111/bjh.15685NLM
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bjh.15685Vancouver
Brierley CK, Jones FM, Hanlon K, Peniket AJ, Hatton C, Collins GP, Schuh A, Medd P, Clark A, Ward J, Rocha VG. Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [Internet]. British journal of haematology. 2019 ; 184( 4): 547-557.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1111/bjh.15685
